Studies on pulmonary fibrosis have demonstrated that FX inhibits α-SMA, collagen I, and fibronectin expression in vitro and attenuates bleomycin-induced pulmonary fibrosis in vivo [21]. The gene discussed is ACTA1; the disease is pulmonary fibrosis.